ArticleESMO open2026

Corrigendum to "Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028": [ESMO Open 10 (2025) 104295].

M Donia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.